Journals / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 3

Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas

Pages
677–682
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CIMT may be used to evaluate adrenal incidentaloma patients for early cardiovascular risk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Adrenal incidentalomas have been associated with increased cardiovascular risk and have a prevalence as high as 10%.
📊
Key Findings & Data:Materials and methods: Patients who were referred to the endocrinology clinic for adrenal incidentaloma between 2014 and 2019 were assessed with 1 mg dexamethasone suppression test, 24-h urine metanephrines and normetanephrines, plasma aldosterone to renin ratio.
💡
Conclusion & Impact:CIMT may be used to evaluate adrenal incidentaloma patients for early cardiovascular risk.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Adrenal incidentalomas have been associated with increased cardiovascular risk and have a prevalence as high as 10%. This study aims to evaluate carotid- intima media thickness (CIMT), left ventricular mass, and epicardial adipose tissue thickness in nonfunctioning adrenal incidentaloma patients and compare their results with healthy controls. Materials and methods: Patients who were referred to the endocrinology clinic for adrenal incidentaloma between 2014 and 2019 were assessed with 1 mg dexamethasone suppression test, 24-h urine metanephrines and normetanephrines, plasma aldosterone to renin ratio. Age and gender-matched subjects without an adrenal mass formed the control group. Left ventricular mass, epicardial adipose tissue thickness, and CIMT of both groups were measured. Results: A total of 41 adrenal incidentaloma patients (21 female, 52.5%) and 40 healthy controls (19 female, 46.3%) were included in the study. Patients with adrenal incidentalomas had increased CIMT. No differences were observed in left ventricle mass or epicardial adipose tissue thickness. There was no correlation between CIMT and adenoma size or serum cortisol (p = 0.2 and p = 0.6, respectively). There was a statistically significant correlation between CIMT and age (p = 0.016, r = 0.295). HBA1c (p = 0.001) and age (p = 0.05) were independently associated with CIMT in regression analysis. Conclusion: Adrenal incidentaloma patients need to be monitored for cardiac dysfunction. CIMT may be used to evaluate adrenal incidentaloma patients for early cardiovascular risk.

🔖

Cite This Article

CAN, B., CAN, B., ÖZER, P. K., ÇAKLILI, Ö. T. (2022). Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 3, 677–682. https://ajindex.com/articles/609302

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J et al. Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. European Journal of Endocrinology 2016
  2. 175 (2): 1-34. doi: 10.1530/EJE-16-0467 2. Davenport C, Liew A, Doherty B, Win HH, Misran H et al. The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 2011
  3. 40 (1): 80-83. doi: 10.1007/s12020- 011-9445-6 3. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vascular Health and Risk Management 2005
  4. 1 (4): 291-299. doi: 10.2147/vhrm.2005.1.4.291 4. Tsai CH, Pan CT, Chang YY, Chen ZW, Wu VC et al. Left ventricular remodelling and dysfunction in primary aldosteronism. Journal of Human Hypertension 2021
  5. 35 (2): 131-147. doi: 10.1038/s41371-020-00426-y 5. Galetta F, Franzoni F, Bernini G, Poupak F, Carpi A et al. Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomedicine & Pharmacotherapy 2010
  6. 64 (7): 505-509. doi: 10.1016/j. biopha.2009.09.014 6. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C et al. Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. The Journal of Clinical Endocrinology and Metabolism 2000
  7. 85 (4): 1440- 1448. doi: 10.1210/jcem.85.4.6515 7. Paschou SA, Kandaraki E, Dimitropoulou F, Goulis DG, Vryonidou A. Subclinical Cushing’s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis. Endocrine 2016
  8. 51 (2): 225-235. doi: 10.1007/s12020-015-0776-6 8. Halcox JP, Donald AE, Ellins EA, Witte DR, Shipley MJ et al. Endothelial function predicts progression of carotid intimamedia thickness. Circulation 2009
  9. 119 (7): 1005-1012. doi: 10.1161/CIRCULATIONAHA.108.765701 9. Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. The International Journal of Biochemistry & Cell Biology 2011
  10. 43 (12): 1651- 1654. doi: 10.1016/j.biocel.2011.09.006 10. Caliskan M, Caklili OT, Caliskan Z, Duran C, Çiftçi FC et al. Does gestational diabetes history increase epicardial fat and carotid intima media thickness? Echocardiography 2014
  11. 31 (10): 1182-1187. doi: 10.1111/echo.12597 11. Bauml MA, Underwood DA. Left ventricular hypertrophy: an overlooked cardiovascular risk factor. Cleveland Clinic Journal